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In recent decades, the United States experienced increasing prevalence and incidence of
diabetes, accompanied by large disparities in county-level diabetes prevalence and inci-
dence. However, whether these disparities are widening, narrowing, or staying the same
has not been studied. We examined changes in disparity among U.S. counties in diagnosed
diabetes prevalence and incidence between 2004 and 2012.
Methods
We used 2004 and 2012 county-level diabetes (type 1 and type 2) prevalence and inci-
dence data, along with demographic, socio-economic, and risk factor data from various
sources. To determine whether disparities widened or narrowed over the time period, we
used a regression-based β-convergence approach, accounting for spatial autocorrelation.
We calculated diabetes prevalence/incidence percentage point (ppt) changes between
2004 and 2012 and modeled these changes as a function of baseline diabetes prevalence/
incidence in 2004. Covariates included county-level demographic and, socio-economic
data, and known type 2 diabetes risk factors (obesity and leisure-time physical inactivity).
Results
For each county-level ppt increase in diabetes prevalence in 2004 there was an annual
average increase of 0.02 ppt (p<0.001) in diabetes prevalence between 2004 and 2012,
indicating a widening of disparities. However, after accounting for covariates, diabetes prev-
alence decreased by an annual average of 0.04 ppt (p<0.001). In contrast, changes in dia-
betes incidence decreased by an average of 0.04 ppt (unadjusted) and 0.09 ppt (adjusted)
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for each ppt increase in diabetes incidence in 2004, indicating a narrowing of county-level
disparities.
Conclusions
County-level disparities in diagnosed diabetes prevalence in the United States widened
between 2004 and 2012, while disparities in incidence narrowed. Accounting for demo-
graphic and, socio-economic characteristics and risk factors for type 2 diabetes narrowed
the disparities, suggesting that these factors are strongly associated with changes in dispar-
ities. Public health interventions that target modifiable risk factors, such as obesity and
physical inactivity, in high burden counties might further reduce disparities in incidence and,
over time, in prevalence.
Introduction
The health and economic burdens of diabetes have been well documented and are major public
health concerns [1, 2]. In recent decades, both prevalence and incidence of diabetes have
increased in the United States. From 1980 to 2012, the prevalence of age-adjusted diagnosed
diabetes increased from 3.7% to 8.4% among the U.S. civilian population aged18 years [3].
Over the same period, among adults aged 18–79 years the annual age-adjusted diabetes inci-
dence increased from 3.5 per 1000 per year to 7.1 per 1000 [4]. It has been projected that diabe-
tes prevalence would increase to as high as 33% and diabetes incidence would increase to 15
per 1000 of the U.S. adults population by 2050 [5]. While diabetes burden is still high, a recent
analysis showed that diabetes prevalence and incidence leveled off during 2008–2012 [6].
In addition to the high burden, geographical disparities exist between counties for both
prevalence and incidence of diabetes [7–13]. A ‘diabetes belt’, or a swath of contiguous counties
with high diabetes prevalence, primarily located in the South, was previously described [8]. In
addition, spatial clusters of low prevalence were found in the Midwest [13]. However, the
extent to which disparities in diabetes prevalence and incidence across U.S. counties have
changed over time is not known.
Elimination of health disparities, including those based on geographic location, is an over-
arching goal of the U.S. Healthy People 2020 initiative to help all population groups achieve
high levels of health [14]. Examining the changes in geographic variation in diabetes outcomes
is essential for monitoring progress in achieving disparity goals, as well as assessing the impact
of past policy efforts and guiding decisions to prioritize future interventions.
The focus of this study was to determine whether county-level disparities in diabetes preva-
lence and incidence (type1 and type 2) have been widening or narrowing over time. We used a
regression-based β-convergence approach to examine changes in disparities in the U.S. county-
level diabetes prevalence and incidence between 2004 and 2012 relative to their starting levels.
Because national level findings may not apply to lower geographic levels, we also conducted
similar analyses by the U.S. census region and by state.
Methods
This study is solely based on the publicly available estimated county-level data from the United
States. It did not involve human participant, specimens or tissue samples, or vertebrate
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animals, embryos or tissues. Therefore, this study did not require an approval from institu-
tional review board.
Counties Assessed
We analyzed data from all 3109 counties in the 48 contiguous states and the District of Colum-
bia. We excluded Alaska and Hawaii because the outcome variables are spatially auto-corre-
lated, preventing calculation of significance levels in non-contiguous areas. (http://
geodacenter.asu.edu/node/402#lisaisle, Accessed August 2, 2015).
Variables
County-level estimates of diagnosed diabetes (type 1 and type 2 combined) prevalence and
incidence for 2004 and 2012 were obtained from data annually published by the Centers for
Disease Control and Prevention (CDC) [15, 16]. The starting year (2004) was the first year for
which county level data are available. The CDC’s county level estimates of diabetes prevalence
and incidence are modeled based on a Bayesian small area estimation approach that uses data
from CDC’s Behavioral Risk Factor Surveillance System (BRFSS) and the U.S. Census Bureau’s
Population Estimates Program [17, 18].
In 2011, BRFSS began using cell phones in addition to landline phones to interview respon-
dents [19]. Although the inclusion of cell phones appears to have had minimal effect on diabe-
tes prevalence estimates [19], we conducted sensitivity analyses to assess its impact on our
analyses.
Covariates included county-level demographic and socio-economic characteristics, and obe-
sity and leisure-time physical inactivity prevalence using data from 2004 if available. If 2004
data were not available we used the data from closest year; 2003 data were used for metropoli-
tan statistical area (MSA) designation of counties and 2000 data were used for educational
attainment, because 2004 data were not available. Demographic factors included age distribu-
tion (percentage of adults 20–43 years (reference), 44–64 years, or65 years) and sex (percent-
age of the population aged20 years that were female). These variables were from the U.S.
Census Bureau population estimates data [20]. Socioeconomic factors included median house-
hold income from the U.S. Census Bureau Small Area Income and Poverty Estimates [21] (in
natural logarithm because of skewedness); MSA designation of counties, from the United States
Department of Agriculture County typology codes [22]; and educational attainment (percent-
age of adults age 25 and older with less than high school degree (reference), high school, some
college or associate degree, or bachelor’s degree or higher) and race/ethnicity (percentage of
adults non-Hispanic white (reference), non-Hispanic black or African American (hereafter we
use the term non-Hispanic black), Hispanic, non-Hispanic Asian, and “other race/ethnicity”)
from the U.S. Census Bureau. Diabetes risk factors included the percentage of adults who were
obese (defined as having a body mass index of30 kg/m2 based on self-reported height and
weight) [23] and the percentage of adults who self-reported engaging in no leisure-time physi-
cal activity [24]. Both of these are estimated from CDC.
Analytic Approach
To explore geographical patterns of change, we mapped the percentage-point (ppt) differences
between 2004 and 2012 in diabetes prevalence and incidence estimates in adults for each
county. To determine whether disparities widened or narrowed over the time period, we mod-
eled these changes as a function of the baseline (2004) prevalence and incidence. Specifically,
we used regression-based β-convergence, an approach commonly used to analyze “economic
convergence”, in which areas that have low initial levels of economic development achieve
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higher growth rates over time than those with initially high levels of economic development
[25]. Recently, this concept has also been applied to measuring changes in disparity between
populations in health care expenditures [26–29] and health outcomes [30]. With this method,
we examined the β coefficient derived from a regression model that measures changes in diabe-
tes prevalence and incidence between 2004 and 2012, relative to the diabetes prevalence and
incidence at the start of the time interval (2004). In models that do not control for other covari-
ates, the β coefficient reflects absolute widening or narrowing of county-level disparities; in
models that control for covariates, the β coefficient reflects conditional widening or narrowing
of county-level disparities [26, 30].
We carried out a series of tests to determine the appropriate regression models. First, we
determined whether an ordinary least squares regression was appropriate by testing the spatial
autocorrelation (i.e., if the rate changes in a county are correlated with neighboring counties)
in diabetes prevalence and incidence using the global Moran’s I statistics [31, 32]. We defined
immediately contiguous neighbors using the first-order Queen Contiguity spatial weight
matrix and standardized the weights so that rows summed to 1.0 [31]. The analysis showed
that changes in diabetes prevalence and incidence between 2004 and 2012 were spatially auto-
correlated, suggesting the need to use a spatial regression model rather than an ordinary least
squares regression model, because estimates from the latter would suffer from biases and
inconsistencies [33]. Next, to determine an appropriate spatial regression model, we used
model selection criteria suggested by Anselin [34]. We determined that a spatial lag model
would be appropriate for determining changes in disparity in diabetes prevalence. This model
accounts for spatial autocorrelation in the outcome between one county and its neighboring
counties. However, a spatial error model was better fit for determining changes in disparity in
diabetes incidence. This model accounts for spatial autocorrelation in the residuals between a
county and its neighboring counties, which can result from omitted variables related to the out-
come variable.
For changes in diabetes prevalence and incidence, we first examined unadjusted models
(Model I) and noted whether disparities were widening or narrowing. We then examined a
series of adjusted models, first including demographic factors (Model II), then adding socio-
economic and behavioral risk factors (Model III), to understand the relative contribution of
each factor in explaining the change of diabetes prevalence and incidence.
We examined the following unadjusted (Eq 1) and adjusted (Eq 2) spatial lag models for
changes in diabetes prevalence:
DMi;T0 ¼ aþ cW  DMi;T0 þ bDMi;0 þ εi ð1Þ
DMi;T0 ¼ aþ cW  DMi;T0 þ bDMi;0 þ Xi;0 þ εi ð2Þ
where DMi,T–0 is the ppt change in diabetes prevalence of i
th county between 2004 and 2012.
WDMi,T–0 is the spatially weighted DMi,T–0, adjusting for the DMi,T–0 of immediate neighbors,
whereW is the first order Queen Contiguity Weight matrix used to identify immediate neigh-
bors [31]. ψ is the coefficient for spatial lag term. DMi,0 is diabetes prevalence in the i
th county
in 2004 (i.e., the independent variable). εi is the uncorrelated error term for the i
th county. Xi,0
represents county-level covariate factors in the initial year and ϕ represents the effect of these
factors on the outcome. β is the convergence coefficient; disparity is narrowing if β<0, widen-
ing if β>0, and not changing if β = 0.
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We examined the following unadjusted (Eq 3) and several adjusted (Eq 4) spatial error mod-
els, for changes in diabetes incidence:
DMi;T0 ¼ aþ bDMi;0 þ εi; where ε ¼ lWεþ x ð3Þ
DMi;T0 ¼ aþ bDMi;0 þ Xi;0 þ εi; where ε ¼ lWεþ x ð4Þ
These specifications differ from those used for the diabetes prevalence models in the lag and
error terms. The error term, ε, is now the correlated spatial lagged error term,Wε is spatially
weighted vector of error terms, ξ the vector of uncorrelated error terms, and λ, the coefficient
for spatial error term.
For analyses by census region, we tested both unconditional (Model I) and conditional β-
convergence including all the covariates, accounting for spatial autocorrelation as we did for
national models (Model III). We used an ordinary least squares regression if spatial autocorre-
lation in the outcomes was not observed. For analyses by state, we tested only unconditional β-
convergence without accounting for spatial autocorrelation, because some states have too few
counties to support the full analysis.
After estimating β coefficients using the models specified above, we calculated average
annual ppt changes in diabetes prevalence and incidence by dividing the coefficients by 8 (the
number of years between 2004 and 2012).
Sensitivity analysis
In order to examine if the inclusion of cellphones by BRFSS beginning in 2011 had an impact
on our results, we examined trends in the medians of county estimates of age-adjusted diabetes
prevalence and incidence. We also examined how our results might change by using 2010 data
rather than 2012 data in our models (i.e., using 2004 and 2010 data).
We used Stata v.13 (StataCorp LP; College Station, Texas) for summary statistics and




Average county-level characteristics of counties studied are presented in Table 1. Average
county-level diabetes prevalence increased 2.9 ppt (95% CI: 2.85–2.94) from 8.3% in 2004 to
11.2% in 2012 (average annual increase 0.36 ppt) (Table 1). Average county-level diabetes inci-
dence decreased 0.08 ppt (95% CI: 0.08–0.09), from 1.03% to 0.94% (average annual decrease
0.01ppt).
Largest average increases in diabetes prevalence were in the South census region (3.3 ppt)
and smallest in the West (2.2 ppt). Largest average decreases in diabetes incidence were in the
Midwest (0.09 ppt) and smallest in the Northeast (0.04 ppt) (results not shown).
The patterns of county-level changes in diabetes prevalence and incidence between 2004
and 2012 are presented in Figs 1 and 2, respectively. Moran’s I statistic for change in diabetes
prevalence between 2004 and 2012 was 0.32 (p<0.001), and for incidence was 0.26 (p<0.001),
indicating existence of significant spatial autocorrelation in these outcomes between counties.
Changes in Disparity in Diabetes Prevalence: National Average
The unadjusted β coefficient for change in diabetes prevalence between 2004 and 2012 was pos-
itive: 0.15 ppt (annually 0.02 ppt; p<0.001) for each ppt increase in prevalence in 2004. Thus,
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county level disparity in diabetes prevalence widened over this time period (Table 2, Model I).
After controlling for demographic factors, the coefficient was lower but still positive: 0.08
(annually 0.01 ppt; p<0.001), indicating that demographic factors partly explained the widen-
ing disparity in diabetes prevalence (Table 2, Model II). When socio-economic and behavioral
covariates were also added, the coefficient was negative: -0.32 (annually -0.04 ppt; p<0.001)
(Table 2, Model III), indicating that disparities narrowed after accounting for these factors.
Diabetes prevalence increased more in counties with a higher percentage of non-high school
graduates, non-Hispanic blacks and non-Hispanic American Indians, and middle-aged adults;
those located in MSAs; and in those with a high prevalence of obesity and adults reporting no
leisure time physical activity. There was significant spatial autocorrelation in the change in dia-
betes prevalence between neighboring counties (Table 2, Model III).
Changes in Disparity in Diabetes Incidence: National Average
The unadjusted β coefficient for change in diabetes incidence between 2004 and 2012 was –
0.31ppt (annually -0.04 ppt; p<0.001) for each ppt increase in incidence in 2004, indicating
that disparities between counties narrowed (Table 3, Model I). After controlling for demo-
graphic factors, the decrease in disparities increased to –0.49 ppt (annually -0.06 ppt; p<0.001)
(Table 3, Model II), indicating that these factors contributed to the narrowing disparities.
Table 1. Average county-level characteristics.
Variables Mean SD Minimum Maximum
Diabetes prevalence (%), 2004 8.3 1.6 3.0 14.6
Diabetes prevalence (%), 2012 11.2 2.4 3.6 23.5
Diabetes incidence (%), 2004 1.0 0.2 0.4 2.1
Diabetes incidence (%), 2012 0.9 0.2 0.3 2.4
Demographic factors:
Aged 20–43 years (%), 2004 44.2 7.1 22.2 86.8
Aged 44–64 years (%), 2004 35.3 3.4 10.3 54.0
Aged65 years (%), 2004 20.5 5.2 2.9 44.8
Female (%), 2004 51.0 2.6 26.2 60.2
NH white (%), 2004 82.6 17.7 2.7 99.6
NH black (%), 2004 8.3 13.5 0.0 83.5
Hispanic (%), 2004 6.0 11.4 0.1 96.8
NH Asian (%), 2004 0.9 1.8 0.0 30.7
NH American Indian (%), 2004 1.4 5.6 0.0 85.7
Other races (%), 2004 0.8 0.7 0.0 10.0
Socio-economic factors:
Median household income ($), 2004 38,045 9,566 17,787 94,658
Less than high school degree (%), 2000 22.7 8.7 3.0 65.3
High school, some college or associate degree (%), 2000 60.8 7.0 27.6 81.1
Bachelor degree or higher (%), 2000 16.5 7.8 4.9 63.7
Metro counties a, 2003 0.4 0.5 0.0 1.0
Risk factors:
Obesity prevalence (%), 2004 26.2 3.4 11.7 38.9
Physical inactivity (%), 2004 26.0 5.2 9.2 42.4
NH non-Hispanic; SD standard deviation (from mean)
a counties are in a metropolitan statistical area.
doi:10.1371/journal.pone.0159876.t001
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Disparities in diabetes incidence were further decreased to –0.73 ppt when also controlling for
socio-economic and behavioral factors (annually -0.09 ppt; p<0.001).
Diabetes incidence decreased more in counties with a higher percentage of high school
graduates and a lower percentage of Hispanics, those with a lower percentage of middle-aged
adults, and those with a lower percentage of physically inactive and obese adults (Table 3). The
significant positive spatial error term suggests that unobserved factors influencing the changes
in diabetes incidence in one county were positively associated with the diabetes incidence of
neighboring counties.
Changes in Disparity in Diabetes Prevalence: Region and State
Averages
Positive unadjusted β coefficients indicated that there were widening disparities in county-level
diabetes prevalence in all U.S. census regions (although the change in the Northeast was not
statistically significant). Estimated annual rates of increase in diabetes prevalence ranged from
Fig 1. Percentage point change in county-level prevalance of diagnosed diabetes among U.S. adults between 2004 and 2012.
doi:10.1371/journal.pone.0159876.g001
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0.01 ppt in the South region to 0.02 ppt in the Midwest andWest for each ppt increase in diabe-
tes prevalence in 2004 (Table 4 Model I). When controlling for all covariates the β coefficients
for each region were negative, indicating a conditional narrowing of disparity in diabetes prev-
alence as found in national model (Table 4 Model III).
Results within regions varied by state (Fig 3). In the Northeast, only 1 of 9 states (New
Jersey) had significant widening disparity in county-level diabetes prevalence. In the Mid-
west, 6 of 12 states (Illinois, Indiana, Kansas, Michigan, South Dakota, and Wisconsin) had
widening disparity. In the South, 4 of 16 states (Alabama, South Carolina, Texas, and Vir-
ginia) had widening disparity. In the West, 4 of 11 states (Arizona, Colorado, New Mexico,
and Washington) had widening disparity (excluding Alaska and Hawaii, which were not
evaluated). New York was the only state that had significant narrowing of county-level dis-
parity in diabetes prevalence. In the remaining 33 states, changes in disparities were not sta-
tistically significant (Fig 3).
Fig 2. Percentage point changes in county-level incidence of diagnosed diabetes among U.S. adults between 2004 and 2012.
doi:10.1371/journal.pone.0159876.g002
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Changes in Disparity of Diabetes Incidence: Region and State Averages
We found a narrowing of disparities in county-level diabetes incidence in all regions. Estimated
annual rates of decrease in diabetes incidence was 0.02 ppt in the Northeast, 0.03 ppt in the
Midwest, 0.04 ppt in the West and 0.05 ppt in the South for each ppt increase in diabetes inci-
dence in 2004 (Table 4).
State-level average changes varied widely within regions. In the Northeast, New York and
Pennsylvania had significantly narrowing disparity in diabetes incidence. In the Midwest, dis-
parities narrowed in all states except Nebraska, Ohio, and South Dakota. In the South, a nar-
rowing of disparities was observed in Arkansas, Georgia, Kentucky, Mississippi, North
Carolina, Oklahoma, Tennessee, Texas, and West Virginia. In the West, disparity narrowed in
California, Idaho, Montana, Oregon, Utah, and Wyoming. In the remaining 22 states, changes
in disparities were not statistically significant (Fig 4).
Sensitivity Analysis
An examination of trends in the medians of age-adjusted county-level diabetes prevalence and
incidence, revealed no change in trend in 2011, the year cell phones were introduced. Also,
Table 2. Estimates of percentage point change in county-level diabetes prevalence between 2004 and 2012.†
Variables Model I Model II Model III
β Coef. Z-Val β Coef. Z-Val β Coef. Z-Val
Constant 0.32** 20.2 0.93* 2.0 -1.36 -0.9
Diabetes prevalence (%), 2004 0.15*** 2.9 0.08*** 4.0 -0.32*** -12.1
Changes in diabetes prevalence of neighboring counties (%), 2004–2012 0.45*** 11.2 0.43*** 19.3 0.33*** 14.4
Aged 44–64 years (%), 2004 0.02** 3.2 0.05*** 7.5
Aged65 years (%), 2004 -0.01 -1.9 0.01 1.9
Female (%), 2004 -0.01 -1.1 0.01 1.6
NH black (%), 2004 0.01*** 4.5 0.02*** 7.7
Hispanic (%), 2004 -0.01*** -3.3 -0.01*** -5.8
NH Asian (%), 2004 -0.09*** -7.0 0.01 0.9
NH American Indian (%), 2004 0.01 1.8 0.02*** 5.3
Other races (%), 2004 0.06 1.8 0.07* 2.2
Metro counties (= 1), 2003 -0.05 -1.1 0.15** 3.0
High school, some college or associate degree (%), 2000 -0.02*** -5.3
Bachelor or higher, (%), 2000 -0.07*** -13.7
Logmedian household income($), 2004 0.25 1.6
Obesity prevalence (%), 2004 0.05*** 4.3
Physical inactivity (%), 2004 0.07*** 10.5
R2 0.24 0.27 0.38
Annual average percentage point change for each percent of DM prevalence in 2004 0.02*** 0.01*** -0.04***
† Based on spatial lag regression models.
Model I: Not controlling for covariates; Model II: controlling for distribution of demographic factors; Model III: controlling for distribution of demographic, socio-
economic, and diabetes risk factors (obesity and leisure-time physical inactivity).
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Table 3. Estimates of percentage point change in county-level diabetes incidence between 2004 and 2012.†
Variables Model I Model II Model III
β Coef. Z-Val β Coef. Z-Val β Coef. Z-Val
Constant 0.23*** 13.8 0.290*** 5.9 0.07 0.3
Diabetes incidence (%), 2004 -0.31*** -20.0 -0.490*** -24.7 -0.73*** -34.2
Aged 44–64 years (%), 2004 0.002** 2.8 0.003*** 4.3
Aged65 years (%), 2004 -0.001 -0.7 -0.001* -0.2
Female (%), 2004 0.001 0.8 0.003*** 3.7
NH black (%), 2004 0.003*** 10.5 0.003*** 9.1
Hispanic (%), 2004 -0.001 -1.4 -0.002*** -0.5
NH Asian (%), 2004 -0.014*** -7.4 0.002 0.8
NH American Indian (%), 2004 0.006*** 11.2 0.006*** 12.3
Other races (%), 2004 -0.002 -0.4 -0.001 -0.3
Metro counties (= 1), 2003 -0.010 -1.5 0.007 1.1
High school, some college or associate degree (%), 2000 -0.003*** -4.1
Bachelor degree or higher (%), 2000 -0.01*** -10.7
Logmedian household income ($), 2004 0.02 0.7
Obesity prevalence (%), 2004 0.01*** 5.2
Physical inactivity (%), 2004 0.01*** 10.4
Spatial error term (λ) 0.57*** 28.5 0.60*** 31.2 0.55 *** 27.0
R2 0.27 0.33 0.44
Annual average percentage point change for each percent of DM incidence in 2004 -0.04*** -0.06 -0.09***
†Based on spatial error regression models
Model I: Not controlling for covariates; Model II: controlling for distribution of demographic factors; Model III: controlling for distribution of demographic, socio-
economic, and behavioral risk factors.






Table 4. Estimated annual percentage point changes in county-level diabetes prevalence and incidence between 2004 and 2012 for each percent-
age point increase in diabetes prevalence or incidence in 2004 by census region.
Census region No. of counties Prevalence1 Incidence2
Model I Model III Model I Model III
Northeast 3 217 0.010 -0.085*** -0.024*** -0.085***
Midwest 1055 0.019*** -0.025*** -0.025*** -0.091***
South 1423 0.014*** -0.076*** -0.045*** -0.096***
West 414 0.019** -0.025*** -0.036*** -0.091***
*** = p<0.001
** = p<0.01
1 The estimates are based on spatial lag models.
2 The estimates are based on spatial error models.
3 The estimates are from ordinary least squares regression models.
Model I: Not controlling for covariates; Model III: controlling for distribution of demographic, socio-economic, and behavioral risk factors.
A significant positive result indicates widening county-level disparities in the region; a significant negative result indicates narrowing county-level disparities
in the region.
doi:10.1371/journal.pone.0159876.t004
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when we estimated the changes between 2004 and 2010 data, for each ppt increase in preva-
lence in 2004 the annual percentage point change for the unadjusted model (Model I) of diabe-
tes prevalence was 0.02 (p<0.001) and for diabetes incidence was -0.04 (p<0.001), identical to
the results using 2004 and 2012 data. Results for the adjusted models (Model III) were also
nearly identical, the annual percentage point change for prevalence was -0.05 (p<0.001) (2010
data) vs. -0.04 (2012 data) and for incidence it was -0.11 (p<0.001) (2010 data) vs. -0.09 (2012
data).
Discussion
We found that county-level disparities in diagnosed diabetes prevalence in the United States
widened between 2004 and 2012, while disparities in incidence narrowed. However, results var-
ied by census region and state. Although prior studies have noted geographic disparities in
county-level diabetes prevalence and incidence [8, 13], to our knowledge this is the first to
examine whether these disparities have changed over time. Analyzing rates of change relative
to the initial condition allows us to determine if counties with high prevalence and incidence
are worsening, or if they are becoming more similar to the rest of the counties.
Fig 3. β-Coefficients for changes in county-level prevalence of diagnosed diabetes among adults between 2004 and 2012
for a percent point increase in prevalence in 2004 by state. Positively significant β-Coefficient: county-level disparity in diabetes
prevalence within the state widened between 2004 and 2012 (p<0.05); Negatively significant β-Coefficient: county-level disparity in
diabetes prevalence within the state narrowed between 2004 and 2012;Not statistically significant β-Coefficient (p<0.05); county-
level disparity in diabetes prevalence within the state did not change between 2004 and 2012 (p>0.05).
doi:10.1371/journal.pone.0159876.g003
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Our findings may be explained by several key factors. The decreased county-level disparity
in incidence may be due to a greater reduction in diabetes risk factors in counties with higher
initial burden. A recent national-level study found a leveling off of diabetes incidence during
2008–2012 [6]. Targeted diabetes prevention programs in the U.S. including lifestyle interven-
tions for high risk populations, have shown promising results in reducing diabetes risk and
may have played a role in reducing the level and disparities [35–37]. Furthermore, several stud-
ies have demonstrated a narrowing of the gap in state-level health care expenditures, especially
in physician and other professional services and home health care [26]. If these trends con-
tinue, they may lead to an eventual narrowing of the disparity in prevalence.
Prevalence measures are composed of a mixture of both long-term and recent cases, and the
interplay of diabetes incidence and mortality on diabetes prevalence has been previously dis-
cussed [38]. The increased disparity in prevalence could have been driven by a decline in the
rate and disparities in diabetes-related mortality across the counties. In recent decades, the
United States has witnessed substantial decline in death rates among people with diabetes [39].
Although diabetes incidence has declined, diabetes prevalence will continue to rise if reduc-
tions in mortality outweigh reductions in new cases [38]. Furthermore, geographic disparities
Fig 4. β-Coefficients for changes in county-level incidence of diagnosed diabetes among adults between 2004 and 2012
for a percent point increase in incidence in 2004 by state. Positively significant β-Coefficient: county-level disparity in diabetes
incidence within the state widened between 2004 and 2012 (p<0.05); Negatively significant β-Coefficient: county-level disparity in
diabetes incidence within the state narrowed between 2004 and 2012;Not statistically significant β-Coefficient (p<0.05); county-
level disparity in diabetes incidence within the state did not change between 2004 and 2012 (p>0.05).
doi:10.1371/journal.pone.0159876.g004
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will widen if disparities in diabetes mortality are reduced at a greater rate than disparities in
incidence.
Accounting for demographic characteristics attenuated the widening disparities observed in
prevalence, and increased the narrowing of disparities in incidence. Moreover, when socio-eco-
nomic and behavioral risk factors were additionally considered, the disparities further nar-
rowed, suggesting that these factors are strongly associated with changes in disparities.
Educational attainment, prevalence of obesity, and leisure time physical inactivity are modifi-
able factors contributing to disparities in both prevalence and incidence. Several studies have
shown that socio-economic status and educational attainment are significant predictors of dia-
betes incidence [40, 41]. One Danish longitudinal study suggested that the incidence of diabe-
tes could be lowered by reducing socio-economic inequality [42]. Obesity and physical
inactivity are also well-known risk factors for diabetes [43], and have been shown to mediate
the effect of education [44]. Thus public health interventions targeting counties that have pop-
ulations with low educational attainment and high rates of obesity and physical inactivity
might decrease diabetes burden and county-level disparities. Furthermore, our finding of sig-
nificant spatial autocorrelation suggests that the effects of public health interventions may
occur not only in the target counties but also spill over to surrounding counties.
Strengths and Limitations
This is the first study to examine changes in county-level disparities in diabetes prevalence and
incidence in the United States. A key methodological strength lies in the augmentation β-con-
vergence models to account for significant spatial autocorrelation in the changes in diabetes
prevalence/incidence among U.S. counties. Previous studies using β-convergence models to
examine changes in disparity of health outcomes were primarily based on ordinary least square
regression models and did not test for spatial autocorrelation in the outcomes across the geo-
graphical units [30]. This point is critical because, in the presence of spatial autocorrelation,
estimates from ordinary least square regression models are biased and inconsistent [33].
Our study had several limitations. First, the data used did not allow us to account for undi-
agnosed diabetes or distinguish between type 1 and type 2 diabetes. Factors such as obesity and
leisure-time physical inactivity are only associated with type 2 diabetes; however, as approxi-
mately 95% of all diabetes cases among adults are type 2, the conclusions apply to the great
majority of cases [45]. Second, our analyses are subject to the limitations of ecological analyses,
and county-level results may not be applicable to individuals. Third, our study covered a lim-
ited time period. Because prevalence includes both long-term and recent cases, analysis using
more years of data would likely provide better insight into changes in diabetes prevalence.
Fourth, demographic, socio-economic, and behavioral factors, as well as diabetes status, were
self-reported and are subject to non-response, recall and social desirability bias [8], which
might have varied geographically. In addition, we did not account for changes in these factors
over time, which may not have been uniform over all counties. Fifth, the introduction of cell
phones use by BRFSS in 2011 could have impacted our analyses; however, our sensitivity analy-
ses suggest that this survey change had little effect on our results. Finally, we used data from
2004 and 2012 only, and our fitted model results reflected average annual changes; actual
changes might not have been linear.
Conclusions
Between 2004 and 2012, disparities in U.S. county-level diabetes prevalence increased. How-
ever, baseline demographic, socio-economic, and behavioral characteristics of county popula-
tions accounted for the increased disparity. Over the same time period, cross-county
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disparities in diabetes incidence declined. Public health interventions targeting counties with
high prevalence of obesity and physical inactivity might further reduce county-level disparities
in incidence and, over time, in prevalence.
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